EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adipose Tissue-Derived Stem Cell Extracellular Vesicles Suppress Glioblastoma Proliferation, Invasiveness and Angiogenesis

Dovydas Gečys, Rūta Skredėnienė, Emilija Gečytė, Arūnas Kazlauskas iD, Ingrida Balnytė, Aistė Jekabsone

Cells · 25.04.2023 · 12 (9) · 1247

DOI: 10.3390/cells12091247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 25.04.2023. Verfasst von Dovydas Gečys und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Lithuanian University of Health Sciences, LT-50162 Kaunas, Lithuania. Hauptthemen laut MEDLINE: Glioblastoma, Extracellular Vesicles. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are attractive anticancer drug delivery candidates as they confer several fundamental properties, such as low immunogenicity and the ability to cross biological barriers. Mesenchymal stem cells (MSCs) are convenient producers for high EV yields, and patient-derived adipose tissue MSC-EVs could serve as personalised carriers. However, MSC-EV applications raise critical concerns as their natural cargo can affect tumour progression in both inducing and suppressing ways. In this study, we investigated the effect of adipose tissue-derived mesenchymal stem cell EVs (ASC-EVs) on several glioblastoma (GBM) cell lines to define their applicability for anticancer therapies. ASC-EVs were isolated from a cell-conditioned medium and characterised by size and specific markers. The internalisation of fluorescently labelled ASC-EVs by human GBM cells HROG36, U87 MG, and T98G was evaluated by fluorescent microscopy. Changes in GBM cell proliferation after ASC-EV application were determined by the metabolic PrestoBlue assay. Expression alterations in genes responsible for cell adhesion, proliferation, migration, and angiogenesis were evaluated by quantitative real-time PCR. ASC-EV effects on tumour invasiveness and neoangiogenesis in ovo were analysed on the chicken embryo chorioallantoic membrane model (CAM). ASC-EV treatment reduced GBM proliferation in vitro and significantly downregulated invasiveness-related genes ITGα5 (in T98G and HROG63) and ITGβ3 (in HROG36) and the vascularisation-inducing gene KDR (in all GBM lines). Additionally, an approximate 65% reduction in the GBM invasion rate was observed in CAM after ASC-EV treatment. Our study indicates that ASC-EVs possess antitumour properties, reducing GBM cell proliferation and invasiveness, and can be applied as anticancer therapeutics and medicine carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaExtracellular VesiclesChick EmbryoAnimalsHumansStem CellsAdipose TissueCell Proliferation

Stichwörter der Autor:innen

adipose-derived mesenchymal stem cellschorioallantoic membrane modelextracellular vesiclesgene expression

Autor:innen und Institutionen

  • Institute of Pharmaceutical Technologies, Faculty of Pharmacy, Lithuanian University of Health Sciences, LT-50162 Kaunas, Lithuania.
  • Laboratory of Molecular Cardiology, Institute of Cardiology, Lithuanian University of Health Sciences, LT-50162 Kaunas, Lithuania.
  • Department of Histology and Embryology, Faculty of Medicine, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.
  • Laboratory of Molecular Neurooncology, Neuroscience Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania.
  • Preclinical Research Laboratory for Medicinal Products, Institute of Cardiology, Lithuanian University of Health Sciences, LT-50162 Kaunas, Lithuania.

ORCID-Profile: Arūnas Kazlauskas

Förderung

  • European Regional Development Fund

Zitieren

APA

Gečys, D., Skredėnienė, R., Gečytė, E., Kazlauskas, A., Balnytė, I., & Jekabsone, A. (2023). Adipose Tissue-Derived Stem Cell Extracellular Vesicles Suppress Glioblastoma Proliferation, Invasiveness and Angiogenesis. Cells, 12(9), 1247. https://doi.org/10.3390/cells12091247

Vancouver

Gečys D, Skredėnienė R, Gečytė E, Kazlauskas A, Balnytė I, Jekabsone A. Adipose Tissue-Derived Stem Cell Extracellular Vesicles Suppress Glioblastoma Proliferation, Invasiveness and Angiogenesis. Cells. 2023;12(9):1247. doi:10.3390/cells12091247

BibTeX
@article{Geys2023,
  author = {Gečys, Dovydas and Skredėnienė, Rūta and Gečytė, Emilija and Kazlauskas, Arūnas and Balnytė, Ingrida and Jekabsone, Aistė},
  title = {Adipose Tissue-Derived Stem Cell Extracellular Vesicles Suppress Glioblastoma Proliferation, Invasiveness and Angiogenesis},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {1247},
  doi = {10.3390/cells12091247}
}
Kostenlos starten →